340 related articles for article (PubMed ID: 9164182)
61. Bone marrow uptake of indolent non-Hodgkin lymphoma on PET/CT with histopathological correlation.
Lee EY; Gill H; Wang Y; Kwong YL; Khong PL
Nucl Med Commun; 2015 Oct; 36(10):1035-41. PubMed ID: 26225940
[TBL] [Abstract][Full Text] [Related]
62. Detection of bone marrow abnormalities in patients with Hodgkin's disease by T1 mapping of MR images of lumbar vertebral bone marrow.
Smith SR; Roberts N; Percy DF; Edwards RH
Br J Cancer; 1992 Feb; 65(2):246-51. PubMed ID: 1739624
[TBL] [Abstract][Full Text] [Related]
63. 99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience.
Gmeiner Stopar T; Fettich J; Zver S; Mlinaric-Rascan I; Hojker S; Socan A; Peitl PK; Mather S
Nucl Med Commun; 2008 Dec; 29(12):1059-65. PubMed ID: 18987526
[TBL] [Abstract][Full Text] [Related]
64. Diagnostic difficulties of pure intrasinusoidal bone marrow infiltration of non-Hodgkin's lymphoma: a report of eight cases from India.
Das R; Sachdeva MU; Malhotra P; Das A; Ahluwalia J; Bal A; Jain S; Varma N; Varma S
Jpn J Clin Oncol; 2011 Nov; 41(11):1303-7. PubMed ID: 21940732
[TBL] [Abstract][Full Text] [Related]
65. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging.
Sanal SM; Flickinger FW; Caudell MJ; Sherry RM
J Clin Oncol; 1994 Jul; 12(7):1415-21. PubMed ID: 8021732
[TBL] [Abstract][Full Text] [Related]
66. [Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration].
Tang R; Gui S; Li J; Zhang H; Lu B; Yang P; Fu D; Fu W; Li W; Cai L
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):231-5. PubMed ID: 24666490
[TBL] [Abstract][Full Text] [Related]
67. Detection and significance of bone marrow infiltration at the time of autologous bone marrow transplantation in Hodgkin's disease.
Chopra R; Wotherspoon AC; Blair S; McMillan AK; Mills W; Fielding AK; Linch DC; Goldstone AH
Br J Haematol; 1994 Jul; 87(3):647-9. PubMed ID: 7993812
[TBL] [Abstract][Full Text] [Related]
68. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy.
Adams HJ; Kwee TC; Lokhorst HM; Westerweel PE; Fijnheer R; Kersten MJ; Verkooijen HM; Stoker J; Nievelstein RA
J Magn Reson Imaging; 2014 Jun; 39(6):1394-400. PubMed ID: 24310955
[TBL] [Abstract][Full Text] [Related]
69. Femoral marrow MRI is a non-invasive, non-irradiated and useful tool for detecting bone marrow involvement in non-Hodgkin lymphoma.
Ikeda S; Tsunoda S; Koyama D; Suzuki M; Sukegawa M; Misawa K; Hojo H; Zhu X; Utano K; Ohta M
J Clin Exp Hematop; 2021 Jun; 61(2):78-84. PubMed ID: 33551438
[TBL] [Abstract][Full Text] [Related]
70. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging.
Rahmouni A; Montazel JL; Divine M; Lepage E; Belhadj K; Gaulard P; Bouanane M; Golli M; Kobeiter H
Radiology; 2003 Dec; 229(3):710-7. PubMed ID: 14593191
[TBL] [Abstract][Full Text] [Related]
71. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
72. Accuracy and relative value of bone marrow aspiration in the detection of lymphoid infiltration in non-Hodgkin lymphoma.
Musolino A; Guazzi A; Nizzoli R; Panebianco M; Mancini C; Ardizzoni A
Tumori; 2010; 96(1):24-7. PubMed ID: 20437853
[TBL] [Abstract][Full Text] [Related]
73. Quantitative magnetic resonance studies of lumbar vertebral marrow in patients with refractory or relapsed Hodgkin's disease.
Smith SR; Williams CE; Edwards RH; Davies JM
Ann Oncol; 1991 Feb; 2 Suppl 2():39-42. PubMed ID: 2049319
[TBL] [Abstract][Full Text] [Related]
74. Assessment of bone marrow involvement by magnetic resonance imaging in small cell lung cancer. No significant change of staging.
Milleron BJ; Le Breton C; Carette MF; Cadranel JL; Akoun GM
Chest; 1994 Oct; 106(4):1030-5. PubMed ID: 7924470
[TBL] [Abstract][Full Text] [Related]
75. Role of 99mTc-hexakis-2-methoxyisobutylisonitrile for detecting marrow metastases in childhood solid tumours.
Berberoğlu K; Unal SN; Kebudi R; Türkmen C; Cantez S
Nucl Med Commun; 2005 Dec; 26(12):1075-80. PubMed ID: 16264353
[TBL] [Abstract][Full Text] [Related]
76. (Smoldering) multiple myeloma: mismatch between tumor load estimated from bone marrow biopsy at iliac crest and tumor load shown by MRI.
Bauer F; Sauer S; Weinhold N; Delorme S; Wennmann M
Skeletal Radiol; 2023 Dec; 52(12):2513-2518. PubMed ID: 37300710
[TBL] [Abstract][Full Text] [Related]
77. Bilateral trephine bone marrow biopsies in Hodgkin's and non-Hodgkin's lymphoma.
Menon NC; Buchanan JG
Pathology; 1979 Jan; 11(1):53-7. PubMed ID: 431979
[TBL] [Abstract][Full Text] [Related]
78. A prospective study of magnetic resonance imaging in lymphoma staging.
Skillings JR; Bramwell V; Nicholson RL; Prato FS; Wells G
Cancer; 1991 Apr; 67(7):1838-43. PubMed ID: 2004296
[TBL] [Abstract][Full Text] [Related]
79. Quantitative magnetic resonance imaging in autologous bone marrow transplantation for Hodgkin's disease.
Smith SR; Williams CE; Edwards RH; Davies JM
Br J Cancer; 1989 Dec; 60(6):961-5. PubMed ID: 2605106
[TBL] [Abstract][Full Text] [Related]
80. Clinicopathological Features of Bone Marrow Infiltration in Hodgkin Lymphoma. Should Bone Marrow Staging Be Done Only in High Risk Patients?
Sudalaimuthu M; Basu D
Turk Patoloji Derg; 2017; 33(2):129-133. PubMed ID: 28272679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
